Abstract
 Cell & Gene Therapy Insights brought together a panel of industry experts to discuss the technological barriers to scaling up LV vector production and how they can be overcome. Here are some of the highlights… 
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
